Distributed VTM outside of VTM Guidance and without clearance.
Source facts
Action
The firm distributed a recall notification via email on 07/12/2022 dated 07/11/2022. This notification identifies the reason for recall to be that all vials of VTM distributed to the United States had not obtained 510K clearance and they weren't approved by FDA under the VTM Enforcement Policy. Customers are asked to identify any unused product and destroy it on-site. Additionally, testing institutions that have used product should evaluate previously obtained test results and evaluate the need to re-test patients. The firm has communicated they intend to apply to FDA for 510K clearance in the future for the recalled device. Customers with any questions are to conact Lei Fan at +86-18938033981 or market@hbxl.net.
Initiated
2022-07-12
Root cause
No Marketing Application
Distribution
Worldwide distribution - US Nationwide distribution in the states of CA, FL, IL & NY. The country of China.
Recall number
Z-1399-2022
Recall status
Open, Classified
CDRH record ID
195024
FDA record created
2022-08-08
Recall event number
90602
Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.
Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.